Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.77 USD | +2.94% | +11.91% | +66.73% |
02:17pm | Stifel Adjusts Price Target on Tandem Diabetes Care to $55 From $45, Maintains Buy Rating | MT |
01:49pm | Citi Upgrades Tandem Diabetes Care to Buy, Price Target at $57 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.73% | 318.56Cr | |
-6.46% | 18TCr | |
+3.39% | 11TCr | |
-3.68% | 6.79TCr | |
+5.44% | 5.2TCr | |
+5.70% | 4.33TCr | |
+4.03% | 4.18TCr | |
+25.42% | 3.25TCr | |
+14.00% | 2.57TCr | |
-4.29% | 2.45TCr |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Citigroup Adjusts Price Target on Tandem Diabetes Care to $31 From $33, Maintains Neutral Rating